Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BPTH Bio-Path Holdings, Inc.

交易中 04-25 11:48:16 EDT

2.59

+0.09

+3.60%

最高2.62	最低2.36	成交量10.66万
今开2.49	昨收2.50	日振幅10.37%
总市值405.40万	流通市值180.75万	总股本156.53万
成交额25.79万	换手率15.28%	流通股本69.79万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BPTH","market":"US","secType":"STK","nameCN":"Bio-Path Holdings, Inc.","latestPrice":2.5899,"timestamp":1714060092773,"preClose":2.5,"halted":0,"volume":106627,"delay":0,"floatShares":697900,"shares":1565300,"eps":-39.79832,"marketStatus":"交易中","marketStatusCode":2,"change":0.0899,"latestTime":"04-25 11:48:16 EDT","open":2.49,"high":2.6199,"low":2.3606,"amount":257896.35778060002,"amplitude":0.10372,"askPrice":2.59,"askSize":101,"bidPrice":2.5,"bidSize":130,"shortable":3,"etf":0,"ttmEps":-39.79832,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1714075200000},"adr":0,"adjPreClose":2.5,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.43,"preClose":2.5,"latestTime":"09:28 EDT","volume":3689,"amount":9004.204162799999,"timestamp":1714051686858},"postHourTrading":{"tag":"盘后","latestPrice":2.45,"preClose":2.49,"latestTime":"19:36 EDT","volume":1680,"amount":4155.985,"timestamp":1714001762635},"volumeRatio":0.017186},"requestUrl":"/m/hq/s/BPTH?invite=TIGER025","defaultTab":"news","newsList":[{"id":"2430894482","title":"Bio-Path Holdings, Inc.盘中异动 股价大跌5.20%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430894482","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430894482?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:57","pubTimestamp":1714053460,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时57分，Bio-Path Holdings, Inc.股票出现波动，股价快速下挫5.20%。截至发稿，该股报2.36美元/股，成交量2.3705万股，换手率1.51%，振幅4.82%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.47%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425215740792377d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425215740792377d4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429695921","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大跌12.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429695921","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429695921?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:32","pubTimestamp":1713792727,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时32分，Bio-Path Holdings, Inc.股票出现异动，股价快速下跌12.12%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。消息层面，截至21时32分，《Roth MKM：重申Bio-Path Hldgs评级，由买入调整至买入评级, 目标价40.00美元。》资讯为影响Bio-Path Holdings, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222132078b464ee4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222132078b464ee4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428540916","title":"Bio-Path Holdings, Inc.盘中异动 早盘急速跳水6.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428540916","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428540916?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:31","pubTimestamp":1713533485,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日21时31分，Bio-Path Holdings, Inc.股票出现波动，股价急速跳水6.66%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。消息层面，截至21时31分，《Roth MKM：重申Bio-Path Hldgs评级，由买入调整至买入评级, 目标价40.00美元。》资讯为影响Bio-Path Holdings, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419213125861e7730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419213125861e7730&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428250592","title":"Bio-Path Holdings, Inc.盘中异动 快速上涨65.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428250592","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428250592?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:31","pubTimestamp":1713447071,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时31分，Bio-Path Holdings, Inc.股票出现波动，股价快速上涨65.12%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Bio-Path Holdings, Inc.、Citius Pharmaceuticals, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Bio-Path Holdings, Inc.、Benitec Biopharma Inc.、Soligenix, Inc.较为活跃，换手率分别为1580.27%、43.59%、23.06%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Imunon, Inc.、Abvc Biopharma, Inc.，振幅分别为14.81%、14.04%、11.77%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418213111879098e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418213111879098e6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428055341","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大涨9.73%报3.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428055341","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428055341?lang=zh_cn&edition=full","pubTime":"2024-04-17 22:30","pubTimestamp":1713364215,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日22时30分，Bio-Path Holdings, Inc.股票出现异动，股价大幅上涨9.73%。截至发稿，该股报3.35美元/股，成交量1.7751万股，换手率2.35%，振幅6.76%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417223016861e6bc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417223016861e6bc3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427873419","title":"Bio-Path Holdings, Inc.盘中异动 股价大涨6.89%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427873419","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427873419?lang=zh_cn&edition=full","pubTime":"2024-04-16 22:15","pubTimestamp":1713276927,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日22时15分，Bio-Path Holdings, Inc.股票出现波动，股价急速上涨6.89%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Jaguar Health, Inc.、Palisade Bio, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Palisade Bio, Inc.、Biorestorative Therapies, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为2160.08%、113.82%、97.87%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.、Palisade Bio, Inc.，振幅分别为101.94%、97.81%、71.15%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162215277a532f2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162215277a532f2c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427001591","title":"Bio-Path Holdings, Inc.盘中异动 早盘急速拉升12.13%报3.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427001591","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427001591?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:47","pubTimestamp":1713188877,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时47分，Bio-Path Holdings, Inc.股票出现异动，股价快速上涨12.13%。截至发稿，该股报3.42美元/股，成交量739股，换手率0.10%，振幅0.00%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152147577a52dac5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152147577a52dac5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426415031","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大跌7.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426415031","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426415031?lang=zh_cn&edition=full","pubTime":"2024-04-10 23:00","pubTimestamp":1712761221,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日23时00分，Bio-Path Holdings, Inc.股票出现波动，股价急速跳水7.07%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1757.67%、74.81%、36.52%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Nutriband Inc C/Wts 、Calidi Biotherapeutics, Inc.，振幅分别为73.45%、52.44%、39.64%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041023002187e7f535&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041023002187e7f535&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424765380","title":"Bio-Path Holdings, Inc.盘中异动 大幅跳水5.87%报4.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424765380","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424765380?lang=zh_cn&edition=full","pubTime":"2024-04-03 02:48","pubTimestamp":1712083700,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日02时48分，Bio-Path Holdings, Inc.股票出现异动，股价大幅下挫5.87%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.68%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Gamida Cell Ltd.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Gamida Cell Ltd.较为活跃，换手率分别为928.80%、163.73%、67.64%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Aditxt, Inc.、Gamida Cell Ltd.，振幅分别为104.31%、67.61%、61.39%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040302482087e7dafc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040302482087e7dafc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421814655","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大涨6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421814655","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421814655?lang=zh_cn&edition=full","pubTime":"2024-03-22 21:54","pubTimestamp":1711115664,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日21时54分，Bio-Path Holdings, Inc.股票出现异动，股价急速拉升6.40%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Matinas Biopharma Holdings, Inc.、Outlook Therapeutics, Inc.、Gt Biopharma, Inc.涨幅较大，Outlook Therapeutics, Inc.、180 Life Sciences Corp.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为47.57%、14.99%、10.66%，振幅较大的相关个股有Matinas Biopharma Holdings, Inc.、Nutriband Inc C/Wts 、Jasper Therapeutics Inc C/Wts 24/09/2026 ，振幅分别为49.96%、38.32%、37.02%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222154247a4e8aa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222154247a4e8aa2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420325728","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大涨5.04%报4.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420325728","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420325728?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:32","pubTimestamp":1710941522,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时32分，Bio-Path Holdings, Inc.股票出现波动，股价大幅拉升5.04%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Jaguar Health, Inc.、Taysha Gene Therapies, Inc.、Immuneering Corporation涨幅较大，Jaguar Health, Inc.、Tc Biopharm  Plc、Nls Pharmaceutics Ltd.较为活跃，换手率分别为35.15%、29.23%、14.75%，振幅较大的相关个股有Jaguar Health, Inc.、Taysha Gene Therapies, Inc.、Atossa Therapeutics, Inc.，振幅分别为11.47%、10.31%、9.68%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320213202879d627a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320213202879d627a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420276830","title":"Bio-Path Holdings, Inc.盘中异动 股价大跌7.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420276830","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420276830?lang=zh_cn&edition=full","pubTime":"2024-03-19 22:30","pubTimestamp":1710858619,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日22时30分，Bio-Path Holdings, Inc.股票出现波动，股价急速下跌7.20%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Fusion Pharmaceuticals Inc.、Moolec Science Sa C/Wts 、知临集团涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为784.29%、388.58%、134.78%，振幅较大的相关个股有Enveric Biosciences, Inc.、Tracon Pharmaceuticals, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为50.00%、47.94%、31.07%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319223019861df6e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319223019861df6e4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420285940","title":"Bio-Path Holdings, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420285940","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420285940?lang=zh_cn&edition=full","pubTime":"2024-03-19 01:49","pubTimestamp":1710784141,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日01时49分，Bio-Path Holdings, Inc.股票出现波动，股价快速拉升5.02%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Artelo Biosciences Inc C/Wts 20/06/2024 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Zyversa Therapeutics, Inc.、Immuneering Corporation、Jaguar Health, Inc.较为活跃，换手率分别为142.98%、43.44%、31.03%，振幅较大的相关个股有Artelo Biosciences Inc C/Wts 20/06/2024 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Immuneering Corporation，振幅分别为443.52%、71.48%、67.02%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031901490187e79d19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031901490187e79d19&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419682903","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大跌8.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419682903","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419682903?lang=zh_cn&edition=full","pubTime":"2024-03-13 21:32","pubTimestamp":1710336751,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日21时32分，Bio-Path Holdings, Inc.股票出现异动，股价大幅跳水8.20%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Nucana Plc、Kintara Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Kintara Therapeutics, Inc.、Nucana Plc、Revelation Biosciences, Inc.较为活跃，换手率分别为92.97%、38.29%、14.37%，振幅较大的相关个股有Nucana Plc、Kintara Therapeutics, Inc.、Cybin Inc.，振幅分别为18.20%、17.94%、16.14%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132132318b2e215c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132132318b2e215c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419666955","title":"Bio-Path Holdings, Inc.盘中异动 下午盘股价大涨6.51%报5.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419666955","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419666955?lang=zh_cn&edition=full","pubTime":"2024-03-13 02:00","pubTimestamp":1710266452,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日02时00分，Bio-Path Holdings, Inc.股票出现波动，股价急速上涨6.51%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Regulus Therapeutics Inc.、Dermata Therapeutics Inc C/Wts 、Artelo Biosciences Inc C/Wts 20/06/2024 涨幅较大，Regulus Therapeutics Inc.、Tc Biopharm  Plc、Scisparc Ltd.较为活跃，换手率分别为730.42%、322.56%、168.84%，振幅较大的相关个股有Regulus Therapeutics Inc.、Dermata Therapeutics Inc C/Wts 、Artelo Biosciences Inc C/Wts 20/06/2024 ，振幅分别为131.16%、80.12%、74.77%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403130200527a4c0031&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403130200527a4c0031&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418582368","title":"Bio-Path Holdings, Inc.盘中异动 大幅下挫9.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418582368","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418582368?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:31","pubTimestamp":1710163900,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时31分，Bio-Path Holdings, Inc.股票出现异动，股价急速下挫9.09%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Biocardia Inc C/Wts 06/08/2024、Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc涨幅较大，Tc Biopharm  Plc、180 Life Sciences Corp.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为706.11%、152.81%、70.55%，振幅较大的相关个股有Equillium, Inc.、Aprea Therapeutics, Inc.、Tc Biopharm  Plc，振幅分别为11.99%、10.86%、9.43%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112131418b243b31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112131418b243b31&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418081495","title":"Bio-Path Holdings, Inc.2023财年实现净利润-16.08百万美元，同比减少15.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418081495","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418081495?lang=zh_cn&edition=full","pubTime":"2024-03-11 00:17","pubTimestamp":1710087438,"startTime":"0","endTime":"0","summary":"12月31日，Bio-Path Holdings, Inc.公布财报，公告显示公司2023财年净利润为-16.08百万美元，同比减少15.93%；其中营业收入为0.00美元，每股基本收益为-33.64美元。机构评级：截至2023年12月31日，当前有1家机构对Bio-Path Holdings, Inc.目标价做出预测，其中目标均价为240.00美元，其中最低目标价为240.00美元，最高目标价为240.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311001721876e4b2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311001721876e4b2f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417776052","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大跌6.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417776052","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417776052?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:31","pubTimestamp":1709908313,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时31分，Bio-Path Holdings, Inc.股票出现异动，股价急速下挫6.26%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、Cero Therapeutics Holdings, Inc.涨幅较大，Scisparc Ltd.、Psyence Biomedical Ltd.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为202.48%、199.11%、173.64%，振幅较大的相关个股有Psyence Biomedical Ltd.、In8Bio, Inc.、Cero Therapeutics Holdings, Inc.，振幅分别为34.25%、17.21%、14.90%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082231537a4adf57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082231537a4adf57&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biopathholdings.com","stockEarnings":[{"period":"1week","weight":-0.2315},{"period":"1month","weight":-0.3413},{"period":"3month","weight":-0.7317},{"period":"6month","weight":-0.7992},{"period":"1year","weight":-0.9078},{"period":"ytd","weight":-0.7311}],"compareEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":-0.0276},{"period":"3month","weight":0.0356},{"period":"6month","weight":0.2307},{"period":"1year","weight":0.2446},{"period":"ytd","weight":0.0633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bio-path Holdings, Inc.正处于发展阶段，其领先的治癌药物Liposomal Grb-2目前处于临床试验阶段。该公司在得克萨斯大学的附属医院安德森癌症研究中心的技术支持下成立，在特许协议下致力于研发新的抗癌药物。其拥有用于系统反义疗法的药物传输平台技术与知识产权。该公司还计划研究脂质体肿瘤定位技术，因为这一技术可以完善目前的传输技术，能进一步提高反义疗法的有效性。除了现有的技术专利，该公司将保持与安德森研究中心主要成员的紧密合作关系，因为后者将来可能为该公司提供潜在药物。该公司还希望将其技术扩展到反义药物之外的抗癌药物，包括安德森研究中心之外的机构所提供的候选药物。该公司成立于2007年5月10日。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.055835},{"month":2,"riseRate":0.4,"avgChangeRate":0.01406},{"month":3,"riseRate":0.6,"avgChangeRate":0.683886},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.13507},{"month":5,"riseRate":0.5,"avgChangeRate":-0.03167},{"month":6,"riseRate":0.6,"avgChangeRate":0.0185},{"month":7,"riseRate":0.3,"avgChangeRate":-0.095426},{"month":8,"riseRate":0.3,"avgChangeRate":-0.14864},{"month":9,"riseRate":0.2,"avgChangeRate":-0.092335},{"month":10,"riseRate":0.6,"avgChangeRate":0.094767},{"month":11,"riseRate":0.4,"avgChangeRate":-0.112549},{"month":12,"riseRate":0.4,"avgChangeRate":-0.110282}],"exchange":"NASDAQ","name":"Bio-Path Holdings, Inc.","nameEN":"Bio-Path"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bio-Path Holdings, Inc.(BPTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bio-Path Holdings, Inc.,BPTH,Bio-Path Holdings, Inc.股票,Bio-Path Holdings, Inc.股票老虎,Bio-Path Holdings, Inc.股票老虎国际,Bio-Path Holdings, Inc.行情,Bio-Path Holdings, Inc.股票行情,Bio-Path Holdings, Inc.股价,Bio-Path Holdings, Inc.股市,Bio-Path Holdings, Inc.股票价格,Bio-Path Holdings, Inc.股票交易,Bio-Path Holdings, Inc.股票购买,Bio-Path Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bio-Path Holdings, Inc.(BPTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}